A detailed history of Norwood Financial Corp transactions in Viatris Inc stock. As of the latest transaction made, Norwood Financial Corp holds 1,220 shares of VTRS stock, worth $12,590. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,220
Previous 1,451 15.92%
Holding current value
$12,590
Previous $15,000 6.67%
% of portfolio
0.02%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

SELL
$11.27 - $13.53 $2,603 - $3,125
-231 Reduced 15.92%
1,220 $14,000
Q4 2023

Jan 11, 2024

SELL
$8.77 - $10.85 $1,043 - $1,291
-119 Reduced 7.58%
1,451 $15,000
Q3 2023

Oct 16, 2023

SELL
$9.59 - $11.35 $1,237 - $1,464
-129 Reduced 7.59%
1,570 $15,000
Q2 2023

Jul 27, 2023

BUY
$9.02 - $10.29 $1,776 - $2,027
197 Added 13.12%
1,699 $16,000
Q4 2022

Jan 13, 2023

SELL
$8.72 - $11.56 $209 - $277
-24 Reduced 1.57%
1,502 $0
Q4 2021

Feb 08, 2022

BUY
$12.09 - $14.68 $18,449 - $22,401
1,526 New
1,526 $21,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $12.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Norwood Financial Corp Portfolio

Follow Norwood Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Norwood Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Norwood Financial Corp with notifications on news.